Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Abdominal application of Talcum Powder or aqueous gel to aid external cephalic version.
ISRCTN ISRCTN87231556
DOI 10.1186/ISRCTN87231556
ClinicalTrials.gov identifier
EudraCT number
Public title Abdominal application of Talcum Powder or aqueous gel to aid external cephalic version.
Scientific title Powder vs Gel for external cephalic version: a randomised trial
Acronym N/A
Serial number at source MEC Ref: No: 818.5
Study hypothesis Is abdominal application of talcum powder better than aqueous gel for external cephalic
version.
Lay summary Lay summary under review 2
Ethics approval Medical Ethics Committee University Malaya Medical Centre, 20 October 2010, ref: 818.5
Study design Randomised trial
Countries of recruitment Malaysia
Disease/condition/study domain Clinical Obstetrics: In the management of Breech presentations.
Participants - inclusion criteria 1. Women from 36 weeks and beyond about to undergo external cephalic version
2. Viable Singleton with breech presentation
3. Gestation ≥ 36 weeks ( check for early confirmation of Gestational Age)
4. Intact membranes
5. Not in established labour ( contractions and cervix ≤ 3cm dilated)
Participants - exclusion criteria 1. Known gross fetal anomaly
2. Severe hypertension ( ≥ 160/110 mmHg or confirmed per-eclampsia)
3. IUGR ( EFW < 2 kg or US AC < 10th centile on our chart)
4. Oligohydramnios ( AFI <5)
5. Antepartum haemorrhage within last seven days.
6. Uterine scar from any source
7. Known Allergy to powder or gel
8. Other potential Obstetric indication for caesarean delivery
8.1. Placenta praevia
8.2. Suspected macrosomia >4kg
8.3. Uterine anomaly ( small fibroids not causing obstruction are acceptable)
8.4. Obstructive pelvic tumour
Anticipated start date 01/01/2011
Anticipated end date 01/12/2012
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 80
Interventions Abdominal application of talcum powder versus aqueous gel to aid in performing external cephalic
version
Primary outcome measure(s) Current primary outcome measures as of 03/01/2013:
1. Procedure satisfaction score by Visual Numerical Rating Scale (VNRS).
2. Success rate of External cephalic version

Previous primary outcome measures until 03/01/2013:
1. Procedure pain score by Visual Numerical Rating Scale (VNRS).
2. Success rate of External cephalic version
Secondary outcome measure(s) 1. Provider's satisfaction with powder or gel using VNRS.
2. Post ECV CTG anomalies
3. Cephalic presentation at Birth
4. Caesarean delivery rate
5. Neonatal Outcome (SCN admission, Apgar score, cord pH )
6. Mode of delivery
Sources of funding University Malaya (Malaysia) ref: RG370/11 HTM
Trial website
Publications
Contact name Dr  Vallikkannu  Narayanan
  Address University Malaya
34, Lorong Pokok Sakat
41100, Klang,
Selangor
  City/town Klang
  Zip/Postcode 41100
  Country Malaysia
Sponsor University Malaya (Malaysia)
  Address Institut Pengurusan dan Pemantauan Penyelidikan
Blok C, Aras 3, Bangunan Institut Pengajian Siswazah (IPS)
  City/town Kuala Lumpur
  Zip/Postcode 50603
  Country Malaysia
  Sponsor website: http://www.ippp.um.edu.my
Date applied 23/11/2012
Last edited 03/01/2013
Date ISRCTN assigned 11/12/2012
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.